DOI: 10.1055/s-00000066

RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren

LinksClose Window

References

Girard N.
Optimizing outcomes in EGFR mutation-positive NSCLC: which tyrosine kinase inhibitor and when?.

Future Oncol 2018;
14: 1117-1132

Download Bibliographical Data

Access:
Access:

We do not assume any responsibility for the contents of the web pages of other providers.